Expert Opinion on Emerging Drugs, Volume 27, Issue 2 (2022)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Emerging Drugs, Volume 27, Issue 2 (2022)

See all volumes and issues
Vol 29, 2024 Vol 28, 2023 Volume 27, 2022 Vol 26, 2021 Vol 25, 2020 Vol 24, 2019 Vol 23, 2018 Vol 22, 2017 Vol 21, 2016 Vol 20, 2015 Vol 19, 2014 Vol 18, 2013 Vol 17, 2012 Vol 16, 2011 Vol 15, 2010 Vol 14, 2009 Vol 13, 2008 Vol 12, 2007 Vol 11, 2006 Vol 10, 2005 Vol 9, 2004 Vol 8, 2003 Vol 7, 2002 Vol 6, 2001 Vol 6, 2001 Vol 5, 2000 Vol 4, 1999 Vol 3, 1998 Vol 2, 1997
Download citations Download PDFs Download issue

Editorial

Editorial
Expert opinion on emerging drugs for lung chronic graft-versus-host disease
Giulia Gabrielli, Irene Dogliotti, Mauro Mangiapia, Chiara Chiappero, Jessica Gill, Chiara Maria Dellacasa, Alessandro Busca & Luisa Giaccone
Pages: 99-101
Published online: 22 Jun 2022
First Page PreviewforExpert opinion on emerging drugs for lung chronic graft-versus-host disease | Full Text | References | PDF (216.5 KB) | EPUB
  • 2751 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Mini-Review

Article
Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency
Andrea Zanichelli, Vincenzo Montinaro, Massimo Triggiani, Francesco Arcoleo, Debora Visigalli & Mauro Cancian
Pages: 103-110
Published online: 26 Jul 2022
AbstractforEmerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency | Full Text | References | PDF (1 MB) | EPUB
  • 220 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review
Epidermal growth factor receptor-targeted therapy for the treatment of non-small cell lung cancer: a review of phase II and III trials
Hong-Lian Lu, Guang-Ling Jie & Yi-Long Wu
Pages: 111-126
Published online: 14 Apr 2022
AbstractforEpidermal growth factor receptor-targeted therapy for the treatment of non-small cell lung cancer: a review of phase II and III trials | Full Text | References | PDF (1.4 MB) | EPUB
  • 418 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Assessing the developing pharmacotherapeutic landscape in hepatitis B treatment: a spotlight on drugs in phase II clinical trials
Rex Wan-Hin Hui, Lung Yi Mak, Wai-Kay Seto & Man-Fung Yuen
Pages: 127-140
Published online: 15 May 2022
AbstractforAssessing the developing pharmacotherapeutic landscape in hepatitis B treatment: a spotlight on drugs in phase II clinical trials | Full Text | References | PDF (1.2 MB) | EPUB
  • 335 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Emerging drugs for the treatment of hepatocellular carcinoma
Walid S Ayoub, Patricia D. Jones, Ju Dong Yang & Paul Martin
Pages: 141-149
Published online: 01 Jun 2022
AbstractforEmerging drugs for the treatment of hepatocellular carcinoma | Full Text | References | PDF (279.1 KB) | EPUB
  • 315 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials
Katharina A. Mayer, Klemens Budde, Bernd Jilma, Konstantin Doberer & Georg A. Böhmig
Pages: 151-167
Published online: 23 Jun 2022
AbstractforEmerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials | Full Text | References | PDF (580.5 KB) | EPUB
  • 538 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Antibody-based therapy for acute myeloid leukemia: a review of phase 2 and 3 trials
Xavier Thomas, Mohamed Elhamri, Alexandre Deloire & Maël Heiblig
Pages: 169-185
Published online: 04 Jul 2022
AbstractforAntibody-based therapy for acute myeloid leukemia: a review of phase 2 and 3 trials | Full Text | References | PDF (3 MB) | EPUB
  • 178 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Treatment for acute respiratory distress syndrome in adults: a narrative review of phase 2 and 3 trials
Denise Battaglini, Chiara Robba, Paolo Pelosi & Patricia R.M. Rocco
Pages: 187-209
Published online: 28 Jul 2022
AbstractforTreatment for acute respiratory distress syndrome in adults: a narrative review of phase 2 and 3 trials | Full Text | References | PDF (1.3 MB) | EPUB
  • 231 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Emerging drugs for the treatment of sickle cell disease: a review of phase II/III trials
Jules M. Ross, Stéphanie Forté & Denis Soulières
Pages: 211-224
Published online: 01 Aug 2022
AbstractforEmerging drugs for the treatment of sickle cell disease: a review of phase II/III trials | Full Text | References | PDF (441.6 KB) | EPUB
  • 374 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update
Joshua Winograd et al.
Review Article | Published online: 14 Jun 2024
Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer’s disease
Hui Jue Wang et al.
Review Article | Published online: 11 Jun 2024
Emerging drugs for the treatment of short bowel syndrome
Tristan Frau et al.
Review Article | Published online: 23 May 2024
Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder
Elliot Hampsey et al.
Review Article | Published online: 8 May 2024
Open Access
View all latest articles